Ortho-est
Drug - Ortho-est
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Estropipate
Multiple ingredients are in alphabetical order.
Strength -
1.5MG
The potency of the active ingredient(s), Estropipate. May repeat for multiple part products.
Applicant -
SUN PHARM INDS (IN)
The firm name holding legal responsibility for Ortho-est. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
089582
The FDA assigned number to Ortho-est. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Ortho-est. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jul 17, 1991
The date Ortho-est was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Ortho-est. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Ortho-est is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Sun Pharmaceutical Industries Ltd
The full name of the firm holding legal responsibility for the new application of Ortho-est.
Ortho-est
|